Cargando…
Targeting AVIL, a New Cytoskeleton Regulator in Glioblastoma
Glioblastoma (GBM) is the most common adult neural malignancy and the deadliest. The standard of care is optimal, safe, cytoreductive surgery followed by combined radiation therapy and alkylating chemotherapy with temozolomide. Recurrence is common and therapeutic options in the recurrent setting ar...
Autores principales: | Cornelison, Robert, Marrah, Laine, Horter, Drew, Lynch, Sarah, Li, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706274/ https://www.ncbi.nlm.nih.gov/pubmed/34948433 http://dx.doi.org/10.3390/ijms222413635 |
Ejemplares similares
-
The Potential for Targeting AVIL and Other Actin-Binding Proteins in Rhabdomyosarcoma
por: Cornelison, Robert, et al.
Publicado: (2023) -
A cytoskeleton regulator AVIL drives tumorigenesis in glioblastoma
por: Xie, Zhongqiu, et al.
Publicado: (2020) -
Rhabdomyosarcomas are oncogene addicted to the activation of AVIL
por: Xie, Zhongqiu, et al.
Publicado: (2022) -
La noche oscura del niño Avilés /
por: Rodríguez Juliá, Edgardo, 1946-
Publicado: (2002) -
Characterization of Minimizers of Aviles–Giga Functionals in Special Domains
por: Marconi, Elio
Publicado: (2021)